Introduction:
Adequate signal to background ratios are critical for the implementation of fluorescence-guided surgery technologies. While local tracer administrations help to reduce the chance of systemic side effects, reduced spatial migration and non-specific tracer diffusion can impair the discrimination between the tissue of interest and the background. To combat background signals associated with local tracer administration, we explored a pretargeting concept aimed at quenching non-specific fluorescence signals. The efficacy of this concept was evaluated in an
in vivo
neuronal tracing set-up.
Methods:
Neuronal tracing was achieved using a wheat germ agglutinin (WGA) lectin
.
functionalized with an azide-containing Cy5 dye (
N
3
-Cy5-WGA
). A Cy7 quencher dye (
Cy7-DBCO
) was subsequently used to yield
Cy7-Cy5-WGA
, a compound wherein the Cy5 emission is quenched by Förster resonance energy transfer to Cy7. The photophysical properties of
N
3
-Cy5-WGA
and
Cy7-Cy5-WGA
were evaluated together with deactivation kinetics
in situ, in vitro
(Schwannoma cell culture)
, ex vivo
(muscle tissue from mice; used for dose optimization), and
in vivo
(
nervus ischiadicus
in THY-1 YFP mice)
.
Results:
In situ
, conjugation of
Cy7-DBCO
to
N
3
-Cy5-WGA
resulted in >90% reduction of the Cy5 fluorescence signal intensity at 30 minutes after addition of the quencher. In cells, pretargeting with the
N
3
-Cy5-WGA
lectin yielded membranous staining, which could efficiently be deactivated by
Cy7-DBCO
over the course of 30 minutes (91% Cy5 signal decrease). In
ex vivo
muscle tissue, administration of
Cy7-DBCO
at the site where
N
3
-Cy5-WGA
was injected induced 80-90% quenching of the Cy5-related signal after 10-20 minutes, while the Cy7-related signal remained stable over time.
In vivo,
Cy7-DBCO
effectively quenched the non-specific background signal up to 73% within 5 minutes, resulting in a 50% increase in the signal-to-background ratio between the nerve and injection site.
Conclusion:
The presented pretargeted fluorescence-quenching technology allowed fast and effective reduction of the background signal at the injection site, while preserving
in vivo
nerve visualization. While this proof-of-principle study was focused on imaging of nerves using a fluorescent WGA-lectin, the same concept could in the future also apply t...